Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

[The effect of fluoxetine on insulin resistance in non diabetic obese patients].

Araya V, Contreras P, Aguirre C, Depix MS, Zura ML.

Rev Med Chil. 1995 Aug;123(8):943-7. Spanish.

PMID:
8657961
4.

Comparisons of glucose-insulin homeostasis following maprotiline and fluoxetine treatment in depressed males.

Chen YC, Shen YC, Hung YJ, Chou CH, Yeh CB, Perng CH.

J Affect Disord. 2007 Nov;103(1-3):257-61. Epub 2007 Feb 22.

PMID:
17320192
5.

Effects of weight loss on insulin secretion and in vivo insulin sensitivity in obese diabetic and non-diabetic subjects.

Escalante-Pulido M, Escalante-Herrera A, Milke-Najar ME, Alpizar-Salazar M.

Diabetes Nutr Metab. 2003 Oct-Dec;16(5-6):277-83.

PMID:
15000438
6.

An open-label pilot study of the combination therapy of metformin and fluoxetine for weight reduction.

Dastjerdi MS, Kazemi F, Najafian A, Mohammady M, Aminorroaya A, Amini M.

Int J Obes (Lond). 2007 Apr;31(4):713-7. Epub 2006 Sep 12.

PMID:
16969361
8.

Persistence of improvement in insulin sensitivity following a dietary weight loss programme.

McLaughlin T, Schweitzer P, Carter S, Yen CG, Lamendola C, Abbasi F, Reaven G.

Diabetes Obes Metab. 2008 Dec;10(12):1186-94. doi: 10.1111/j.1463-1326.2008.00877.x. Epub 2008 May 12.

PMID:
18476986
9.

[Impact of weight loss on adipocytokines, C-reactive protein and insulin sensitivity in hypertensive women with central obesity].

Borges RL, Ribeiro-Filho FF, Carvalho KM, Zanella MT.

Arq Bras Cardiol. 2007 Dec;89(6):409-14. English, Portuguese.

10.

Fluoxetine treatment for weight reduction in steroid-induced obesity: a pilot study in myasthenia gravis patients.

Achiron A, Barak Y, Noy S, Pinhas-Hamiel O.

Eur Neuropsychopharmacol. 1999 Jan;9(1-2):111-3.

PMID:
10082236
11.

[Biochemical markers and methods to assess insulin resistance in normal, obese and hyperandrogenic women].

Sir T, López G, Castillo T, Muñoz S, Durruty P, Calvillán M.

Rev Med Chil. 1997 Sep;125(9):977-85. Spanish.

PMID:
9595787
12.
13.

Aerobic exercise training improves insulin sensitivity without changes in body weight, body fat, adiponectin, and inflammatory markers in overweight and obese girls.

Nassis GP, Papantakou K, Skenderi K, Triandafillopoulou M, Kavouras SA, Yannakoulia M, Chrousos GP, Sidossis LS.

Metabolism. 2005 Nov;54(11):1472-9.

PMID:
16253636
14.

Usefulness of fluoxetine in obese non-insulin-dependent diabetics: a multicenter study.

Daubresse JC, Kolanowski J, Krzentowski G, Kutnowski M, Scheen A, Van Gaal L.

Obes Res. 1996 Jul;4(4):391-6.

15.

[Effects of metformin on insulin resistance in obese and hyperandrogenic women].

Sir T, Castillo T, Muñoz S, López G, Calvillán M.

Rev Med Chil. 1997 Dec;125(12):1457-63. Spanish.

PMID:
9609021
16.

Rosiglitazone is more effective than metformin in improving fasting indexes of glucose metabolism in severely obese, non-diabetic patients.

Brunani A, Caumo A, Graci S, Castagna G, Viberti G, Liuzzi A.

Diabetes Obes Metab. 2008 Jun;10(6):460-7. Epub 2007 Mar 29.

PMID:
17394563
17.

Lower cortisol levels after oral glucose in subjects with insulin resistance and abdominal obesity.

Fernández-Real JM, Ricart W, Casamitjana R.

Clin Endocrinol (Oxf). 1997 Nov;47(5):583-8.

PMID:
9425398
18.

Diet and exercise in the treatment of obesity: effects of 3 interventions on insulin resistance.

Weinstock RS, Dai H, Wadden TA.

Arch Intern Med. 1998 Dec 7-21;158(22):2477-83.

PMID:
9855386
20.

The effect of 1-yr sibutramine treatment on glucose tolerance, insulin sensitivity and serum lipid profiles in obese subjects.

Sabuncu T, Ucar E, Birden F, Yasar O.

Diabetes Nutr Metab. 2004 Apr;17(2):103-7.

PMID:
15244102

Supplemental Content

Support Center